Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 3
2016 8
2017 6
2018 7
2019 10
2020 6
2021 6
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls.
Costas-Insua C, Hermoso-López A, Moreno E, Montero-Fernández C, Álvaro-Blázquez A, Maroto IB, Sánchez-Ruiz A, Diez-Alarcia R, Blázquez C, Morales P, Canela EI, Casadó V, Urigüen L, Perea G, Bellocchio L, Rodríguez-Crespo I, Guzmán M. Costas-Insua C, et al. Among authors: morales p. EMBO Mol Med. 2024 Apr;16(4):755-783. doi: 10.1038/s44321-024-00054-w. Epub 2024 Mar 21. EMBO Mol Med. 2024. PMID: 38514794 Free PMC article.
Activation of CB2R by synthetic CB2R agonist, PM289, improves brain endothelial barrier properties, decreases inflammatory response and enhances endothelial repair.
Bullock TA, Galpayage Dona KNU, Hale JF, Morales P, Jagerovic N, Andrews AM, Ramirez SH. Bullock TA, et al. Among authors: morales p. NeuroImmune Pharm Ther. 2023 Oct 16;2(4):387-400. doi: 10.1515/nipt-2023-0016. eCollection 2023 Dec. NeuroImmune Pharm Ther. 2023. PMID: 38116176 Free PMC article.
Multimodality imaging for investigating constrictive pericarditis.
De Paula Morales KR, Vaz A, Couto RM, Fonseca EKUN. De Paula Morales KR, et al. Eur Heart J Cardiovasc Imaging. 2023 Dec 21;25(1):e64. doi: 10.1093/ehjci/jead255. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37801650 No abstract available.
Editorial: New approaches for the discovery of GPCR ligands.
Morales P, Scharf MM, Johnson CP, Di Pizio A, Hilger D. Morales P, et al. Front Endocrinol (Lausanne). 2023 Aug 21;14:1272700. doi: 10.3389/fendo.2023.1272700. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37670881 Free PMC article. No abstract available.
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.
Figuerola-Asencio L, Morales P, Zhao P, Hurst DP, Sayed SS, Colón KL, Gómez-Cañas M, Fernández-Ruiz J, Croatt MP, Reggio PH, Abood ME, Jagerovic N. Figuerola-Asencio L, et al. Among authors: morales p. ACS Med Chem Lett. 2022 Dec 2;14(1):18-25. doi: 10.1021/acsmedchemlett.2c00325. eCollection 2023 Jan 12. ACS Med Chem Lett. 2022. PMID: 36655130 Free PMC article.
Editorial: Cannabinoids as potential treatment for neurological diseases.
Gómez-Cañas M, Morales P, Satta V, Rodríguez-Cueto C, García C, Sagredo O. Gómez-Cañas M, et al. Among authors: morales p. Front Neurosci. 2022 Dec 20;16:1108101. doi: 10.3389/fnins.2022.1108101. eCollection 2022. Front Neurosci. 2022. PMID: 36605545 Free PMC article. No abstract available.
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
Calvillo-Robledo A, Cervantes-Villagrana RD, Morales P, Marichal-Cancino BA. Calvillo-Robledo A, et al. Among authors: morales p. Life Sci. 2022 Jul 15;301:120596. doi: 10.1016/j.lfs.2022.120596. Epub 2022 Apr 30. Life Sci. 2022. PMID: 35500681 Review.
61 results